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Low Carbohydrate Diet From Plant or Animal Sources and Mortality
Among Myocardial Infarction Survivors
Shanshan Li, MD, Msc, ScD; Alan Flint, MD, DrPH; Jennifer K. Pai, ScD; John P. Forman, MD, Msc; Frank B. Hu, MD, PhD;
Walter C. Willett, MD, DrPH; Kathryn M. Rexrode, MD, MPH; Kenneth J. Mukamal, MD, MPH; Eric B. Rimm, ScD
Background-—The healthiest dietary pattern for myocardial infarction (MI) survivors is not known. Speciﬁc long-term beneﬁts of a
low-carbohydrate diet (LCD) are unknown, whether from animal or vegetable sources. There is a need to examine the associations
between post-MI adherence to an LCD and all-cause and cardiovascular mortality.
Methods and Results-—We included 2258 women from the Nurses’ Health Study and 1840 men from the Health Professional
Follow-Up Study who had survived a ﬁrst MI during follow-up and provided a pre-MI and at least 1 post-MI food frequency
questionnaire. Adherence to an LCD high in animal sources of protein and fat was associated with higher all-cause and
cardiovascular mortality (hazard ratios of 1.33 [95% CI: 1.06 to 1.65] for all-cause mortality and 1.51 [95% CI: 1.09 to 2.07] for
cardiovascular mortality comparing extreme quintiles). An increase in adherence to an animal-based LCD prospectively assessed
from the pre- to post-MI period was associated with higher all-cause mortality and cardiovascular mortality (hazard ratios of 1.30
[95% CI: 1.03 to 1.65] for all-cause mortality and 1.53 [95% CI: 1.10 to 2.13] for cardiovascular mortality comparing extreme
quintiles). An increase in adherence to a plant-based LCD was not associated with lower all-cause or cardiovascular mortality.
Conclusions-—Greater adherence to an LCD high in animal sources of fat and protein was associated with higher all-cause and
cardiovascular mortality post-MI. We did not ﬁnd a health beneﬁt from greater adherence to an LCD overall after MI. ( J Am Heart
Assoc. 2014;3:e001169 doi: 10.1161/JAHA.114.001169)
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O ver the past several decades, improvements in clinicalcare, including more frequent use of reperfusion therapy
and secondary prevention medications, have greatly
increased patients’ survival following myocardial infarction
(MI).1–6 At the same time, the characteristics of MI survivors
have changed, with higher prevalence of obesity, metabolic
syndrome, and type 2 diabetes.1–4
The American Heart Association guidelines for coronary
heart disease state that patients should be instructed to
achieve and maintain a healthy weight (body mass index 18.5
to 24.9 kg/m2) through changes in diet and physical
activity5–8; however, the effect of a weight-loss diet among
MI survivors is unknown. Many nutritionists still recom-
mended low-fat diets for post-MI patients despite the
potential unfavorable effects this may have on triglycerides
and high-density lipoprotein cholesterol.9–11 Low-carbohy-
drate diets (LCDs) have become extremely popular in recent
years. Their purported beneﬁts are generally linked to short-
term weight loss,12 improved fasting glucose and insulin
sensitivity, improved triglycerides and high-density lipoprotein
cholesterol, reduced systemic inﬂammation,12,13 lower sys-
tolic and diastolic blood pressure,12 and reduced overall
glycemic load and risk of type 2 diabetes12,14,15; however,
data on long-term effects of LCDs are sparse, and no data are
available for MI survivors. It is unknown whether an LCD is a
safe weight-loss diet for MI patients. Furthermore, not all
LCDs are equal: They may be rich in animal-based protein and
fat or may be mainly from plant-based sources.
Using a previously developed LCD score (LCDS) based
speciﬁcally on total, animal, and plant sources,16 we pro-
spectively examined the long-term beneﬁt of adhering to an
LCD after initial MI in 2 large existing cohort studies with
dietary information collected both before and after initial MI
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and with long-term follow-up. We hypothesized that an LCD
may have beneﬁts for MI survivors but could be detrimental if
the diet is higher in saturated fat and protein. We hypothe-
sized that greater adherence to an LCD in the period following
MI is associated with lower mortality.
Methods
Study Population
The Nurses’ Health Study is a prospective cohort of 121 700
registered female nurses who were aged between 30 and
55 years at enrollment in 1976.17 The Health Professional
Follow-up Study is a prospective cohort of 51 529 US male
health professionals aged 40 to 75 years at baseline in
1986.18 Participants in both studies received biennial ques-
tionnaires on lifestyle and medical history.
Our study included 2258 women and 1840 men who were
free of cardiovascular disease, stroke, and cancer at the time
of enrollment, survived their initial MI, were free of stroke at
the time of initial MI onset, and provided at least 1 pre-MI and
post-MI food frequency questionnaire (FFQ) before death. We
calculated the post-MI period from the date of the ﬁrst FFQ
returned after the initial MI until death or the end of the study
period (June 30, 2008).
Exposure Assessment
Dietary intake was assessed using a validated FFQ every
4 years.19 A valid FFQ was deﬁned as within a preset
estimated caloric range (600 to 3500 kcal/day for women
and 800 to 4200 kcal/day for men) and had <70 food items
with missing data. The average nutrient intake was calculated
by multiplying the nutrient content for each food, as
assembled from the Harvard University Food Composition
Database, by the frequency of consumption and then summed
across all food items. This FFQ has been validated and shown
to adequately reﬂect average food and nutrient intake over
the previous year (Pearson’s correlations range from 0.5 to
0.7 for total fat, carbohydrate, and protein).19–21
We calculated the percentage of energy from fat, proteins,
and carbohydrates for each study participant and separately
calculated the intake from animal and plant sources.16 We
divided participants into 11 strata for each macronutrient.
Those in the highest stratum were assigned scores of 10 for
fat, 10 for protein, and 0 for carbohydrate. We summed the
scores for percentage of energy from total fat, protein, and
carbohydrate to represent the overall LCDS for each study
participant. The score ranged from 0 (the lowest fat and
protein intake and highest carbohydrate intake) to 30 (the
highest protein and fat intake and lowest carbohydrate
intake). A plant-based LCDS was calculated based on
percentages of energy from carbohydrates, vegetable protein,
and vegetable fat; we calculated the animal-based LCDS in a
similar manner. The higher the score, the more closely the
participant adhered to a speciﬁc type of LCD.16
Conﬁrmation of Incident MI
Study physicians who were blinded to participants’ exposure
status reviewed medical records to conﬁrm incident MI
diagnosis.22 MI was conﬁrmed based on the World Health
Organization’s criteria.23
Outcome Assessment
Our primary outcomes were all-cause and cardiovascular
mortality. After the initial nonfatal MI, deaths occurring during
the follow-up period were identiﬁed from vital records, the
National Death Index, and reports by the participant’s next of
kin or the postal system.24 Cardiovascular mortality consisted
of fatal coronary heart disease or fatal stroke, conﬁrmed
through a review of death certiﬁcates, medical records, or
autopsy reports, with the permission of the next of kin.
Covariate Assessment
Covariates were chosen a priori based on the literature and on
previous studies of MI survival. We considered medication use,
medical history, and lifestyles factors that have been reported
to be associated with MI risk. All covariates were updated with
each questionnaire cycle, and we dropped the following
covariates from themultivariate models because their inclusion
did not change the b-coefﬁcient for the main effect by at least
10%: beta blockermedication use, antihypertensionmedication
use, height, MI site, ST-elevation MI, family history of MI,
hypercholesterolemia, and multivitamin use.
Statistical Analyses
Baseline characteristics by quintile of adherence to the LCD
are presented as means or frequencies. Pre-MI LCDS was
estimated from the most recent FFQ before initial MI onset.
Change of LCDS from pre- to post-MI periods was deﬁned as
the absolute difference of the LCDS (post-MI LCDSpre-MI
LCDS). We categorized each exposure of interest (total, plant-
and animal-based LCD in the post-MI period and changes
from pre- to post-MI periods) into quintiles.
To assess the associations between LCD and post-MI
mortality, a Cox proportional hazards model was used with
time since return of the ﬁrst post-MI FFQ as the underlying
time scale. For analyses of dose-response trends, the
medians of each quintile were ﬁt as a continuous variable.
We evaluated heterogeneity of results for men and women
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using Cochrane Q statistics 25 and then meta-analyzed across
cohorts using a ﬁxed-effect model.26,27 The proportional
hazards assumption was assessed by testing the signiﬁcance
of the interaction term between LCDS and time in the study.
We further performed substitution analysis to estimate the
relative risk for all-cause and cardiovascular mortality asso-
ciated with replacement of 10% energy from animal sources
with plant sources of food.
To evaluate the rate of mortality associated with changes
in the LCDS from before to after MI, we adjusted for
corresponding changes in covariates from pre- to post-MI
periods. For missing data, the missing indicator method was
used for categorical variables and replaced the missing value
for continuous variables with the median change.
To evaluate whether the association between animal-based
LCDs and mortality differed by diabetes status (yes versus
no), we tested for potential effect modiﬁcation using the
likelihood ratio test. We also adjusted for cereal ﬁber, omega-
3 fatty acids, and saturated fat in the multivariate model to
assess whether the association with animal-based LCDs was
driven mainly by these dietary factors.
Participants who returned an FFQ within 1 year of initial MI
may not accurately represent their post-MI diet because the
time frame would bridge the pre- and post-MI periods. In a
sensitivity analysis, we excluded these FFQs and included
only those participants with a subsequent FFQ at least
12 months after MI (total sample size: 1689 men and 2059
women). If the 381 women and 241 men who died before
they completed a post-MI FFQ were substantially different
with respect to their LCDs, we may have introduced a modest
selection bias. Consequently, we estimated the probability of
being selected into this study and assigned each study
participant a weight by the inverse of this probability.28
We also conducted analyses among the subset of partic-
ipants who were in the lower half of the LCDS before initial MI
onset (pre-MI LCDS less than the median of 15). We deﬁned
those who had an LCDS <15 before MI but >15 after MI as
the new adherent group, and those who had an LCDS <15 in
both the pre- and post-MI periods as nonadherent. In this
analysis, we had a sample size of 1059 for women (294 new
adherents and 765 nonadherents) and 804 for men (216 new
adherents and 588 nonadherents).
This study complies with the Declaration of Helsinki. The
Harvard School of Public Health ethics committee approved
the research protocol, and informed consent was obtained
from the study participants.
Results
During follow-up of 2258 women and 1840 men who survived
an initial MI, we conﬁrmed 682 total and 336 cardiovascular
deaths for women and 451 total and 222 cardiovascular
deaths for men. Median interval between initial MI onset and
the ﬁrst post-MI dietary assessment was 2 years. Median
survival time was 8 years for women and 9 years for men. At
the time of ﬁrst post-MI questionnaire, median body mass
index was 26.5 kg/m2 among women and 25.8 kg/m2 among
men. Participants on average increased their consumption of
carbohydrates following MI and thus had a lower LCDS after MI
(Table 1). Spearman correlation coefﬁcients between pre- and
post-MI total LCDSs were 0.31 for women and 0.38 for men;
0.35 and 0.41, respectively, for animal-based LCDSs; and 0.34
and 0.40, respectively, for vegetable-based LCDSs. Prevalence
of baseline diabetes was higher among participants with high
LCDSs.
LCDS Post-MI Analyses
A greater total LCDS was associated with higher all-cause
mortality for women but not for men after adjustment for
time since MI onset, age at diagnosis, and calendar year
(Table 2). A test for trend across increasing quintiles of LCDS
for women was attenuated but remained signiﬁcant after
multivariate adjustment (hazard ratio [HR] 1.31, 95% CI 0.99
to 1.73; Ptrend=0.02, comparing extreme quintiles). The
pooled multivariate HR for total LCDS was 1.13 (95% CI
0.91 to 1.40; P=0.10 for heterogeneity, ﬁfth versus ﬁrst
quintile). A higher animal-based LCDS was associated with
increased all-cause mortality (pooled HR 1.33, 95% CI 1.06 to
1.65), but a higher plant-based LCDS was not (pooled HR
0.95, 95% CI 0.77 to 1.18 comparing ﬁfth and ﬁrst quintiles)
(Table 2).
The higher animal-based LCDS was associated with higher
cardiovascular mortality (pooled HR 1.51, 95% CI 1.09 to
2.07, comparing extreme quintiles), but the plant-based LCDS
was not (Table 2). Substituting 10% energy of animal-based
foods with plant-based food was associated, albeit not
signiﬁcantly, with lower risk for all-cause and cardiovascular
mortality (pooled HR 0.91, 95% CI 0.81 to 1.03 for all-cause
mortality; pooled HR 0.87, 95% CI 0.73 to 1.04 for cardio-
vascular mortality).
Changes in LCDS From Pre- to Post-MI Analyses
In women, an increase in total LCDS was associated with a
trend toward increased risk of all-cause mortality (HR 1.35,
95% CI 0.99 to 1.84; Ptrend=0.01) (Table 3). In particular, a
greater increase in the animal-based LCDS was associated
with higher all-cause and cardiovascular mortality in women
(HR 1.62, 95% CI 1.19 to 2.20 for all-cause mortality; HR 1.97,
95% CI 1.29 to 3.03 for cardiovascular mortality). No
signiﬁcant associations in LCDS dietary change and mortality
were observed in men. After pooling the results from women
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Table 1. Age-Standardized Baseline Characteristics of 2258 Post-MI Women in the Nurses’ Health Study and 1840 Post-MI Men in
the Health Professional Follow-up Study by Quintiles of Total Low-Carbohydrate Diet Score
Women Men
Q1 Q3 Q5 Q1 Q3 Q5
n 407 491 424 410 382 321
Post-MI total LCDS* 3.5 (2.0) 13.4 (1.1) 24.0 (2.6) 4.1 (2.2) 12.4 (1.1) 24.3 (2.7)
Pre-MI total LCDS† 11.3 (6.7) 15.2 (6.8) 19.3 (6.9) 12.2 (7.3) 15.4 (6.3) 19.9 (6.3)
Change of total LCDS from pre- to post MI‡ 7.8 (6.8) 1.8 (6.8) 4.7 (7.1) 8.1 (7.4) 3.0 (6.4) 4.5 (6.5)
Post-MI plant-based LCDS* 6.3 (2.4) 13.9 (0.8) 22.0 (2.2) 6.9 (2.2) 14.0 (0.8) 21.8 (2.6)
Pre-MI plant-based LCDS† 12.0 (5.4) 14.6 (5.2) 17.7 (5.2) 12.2 (5.0) 15.2 (4.9) 17.9 (5.3)
Change of plant-based LCDS from pre- to post-MI periods‡ 5.7 (5.2) 0.7 (5.2) 4.3 (5.4) 5.3 (5.1) 1.2 (4.9) 3.8 (5.5)
Post-MI animal-based LCDS* 2.7 (1.7) 13.0 (1.4) 25.5 (2.5) 2.4 (1.7) 13.0 (1.4) 24.8 (2.8)
Pre-MI animal-based LCDS† 11.1 (7.9) 15.7 (7.2) 19.8 (7.3) 11.2 (7.9) 15.3 (7.0) 20.3 (6.7)
Change of animal-based LCDS from pre- to post-MI periods‡ 8.4 (8.0) 2.7 (7.3) 5.7 (7.4) 8.8 (7.9) 2.3 (7.0) 4.5 (6.9)
Age at diagnosis, y§ 65.1 (8.4) 64.9 (8.6) 64.4 (8.6) 66.0 (9.0) 66.1 (9.1) 66.1 (9.3)
Body mass index, kg/m2 25.8 (5.4) 26.6 (5.2) 28.2 (5.9) 25.3 (3.4) 26.1 (3.7) 26.8 (3.8)
Physical activity, MET hours/week 14.3 (18.2) 14.7 (16.9) 12.7 (17.4) 35.6 (34.0) 32.9 (48.7) 32.1 (38.5)
Smoking status
Never smoker, % 36 32 27 39 37 26
Past smoker, % 55 59 57 49 52 58
Current smoker, % 9 9 16 12 11 16
Currently married, % 52 57 58 88 89 87
Diabetes, % 13 21 36 8 17 24
High blood pressure, % 66 69 72 54 56 59
Elevated cholesterol, % 75 72 78 67 64 65
Aspirin use, % 65 61 62 84 84 79
Lipid-lowering medication use, % 44 52 48 51 56 47
CABG, % 56 56 57 74 75 72
Reproductive factors
Premenopause, % 4 5 4 n/a n/a n/a
Past PMH user, % 31 30 29 n/a n/a n/a
Current PMH user, % 58 57 55 n/a n/a n/a
Post-MI dietary intake
Total energy, kcal/day 1581 (534) 1628 (515) 1607 (536) 2006 (632) 1880 (595) 1927 (658)
Saturated fat, % of energy 6.9 (2.0) 9.0 (2.3) 12.0 (2.5) 6.2 (2.0) 8.2 (2.2) 11.7 (2.7)
Omega-3 fatty acids, % of energy 0.6 (0.3) 0.7 (0.3) 0.9 (0.4) 0.6 (0.3) 0.8 (0.4) 0.8 (0.6)
Trans fat, % of energy 1.2 (0.6) 1.4 (0.6) 1.8 (0.6) 1.2 (0.7) 1.4 (0.6) 1.8 (0.7)
Animal fat, % of energy 9.5 (3.4) 13.3 (4.0) 19.3 (5.4) 8.0 (3.2) 12.1 (3.6) 19.5 (6.0)
Vegetable fat, % of energy 12.3 (4.0) 14.5 (4.8) 17.0 (6.2) 13.1 (4.3) 14.6 (4.9) 17.2 (6.1)
Animal protein, % of energy 9.3 (2.7) 12.8 (3.3) 15.5 (3.8) 9.0 (2.7) 12.5 (3.3) 15.2 (3.7)
Vegetable protein, % of energy 6.0 (1.4) 5.8 (1.3) 5.2 (1.2) 6.5 (1.6) 6.0 (1.3) 5.2 (1.4)
Carbohydrate, % of energy 64.4 (5.6) 53.9 (4.1) 43.2 (5.7) 64.1 (6.1) 53.8 (4.2) 41.1 (6.2)
Cereal fiber intake, g/day 6.7 (3.3) 6.3 (2.9) 5.2 (2.7) 9.5 (4.1) 8.5 (3.7) 6.0 (2.5)
Alcohol intake, g/day 3.7 (7.5) 4.6 (9.3) 3.6 (7.2) 8.1 (12.3) 9.4 (12.8) 8.9 (11.4)
Continued
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and men, the pooled HR for animal-based LCDS was 1.30
(95% CI 1.03 to 1.65) for all-cause mortality and 1.53 (95% CI
1.10 to 2.13) for cardiovascular mortality, comparing extreme
quintiles (Table 3).
Subgroup Analyses
We did not observe signiﬁcant effect modiﬁcation by diabetes
status (Pinteraction=0.94 for women and 0.75 for men).
Associations between the animal-based LCD and mortality
were attenuated after additionally adjusting for saturated fat
(pooled HR 1.21, 95% CI 0.93 to 1.59 for all-cause mortality;
pooled HR 1.45, 95% CI 0.98 to 2.14 for cardiovascular
mortality, comparing the highest and lowest quintiles).
A change in the animal-based LCDS from below to above
the median was associated with higher all-cause mortality
(pooled HR 1.28, 95% CI 1.03 to 1.60, ﬁfth versus ﬁrst
quintile) and higher cardiovascular mortality (pooled HR 1.42,
95% CI 1.04 to 1.93, ﬁfth versus ﬁrst quintile) (Figure), but
change in total LCDS or plant-based LCDS was not (Figure).
Sensitivity Analyses
Results were similar after using the inverse probability
weighting method to account for potential selection bias,
with pooled HRs for total mortality of 1.17 (95% CI 0.96 to
1.43) for the total LCDS, 1.14 (95% CI 0.93 to 1.40) for the
vegetable-based LCDS, and 1.30 (95% CI 1.06 to 1.61) for
the animal-based LCDS. In a separate sensitivity analysis, the
results were similar when we further excluded FFQs returned
within 1 year after MI (data not shown). We did not observe
signiﬁcant violation of the proportional hazards assumption.
Discussion
In our combined prospective cohorts of MI survivors, we found
that adherence to an LCD overall was not associated with all-
cause or cardiovascular mortality. There was no beneﬁt from
adherence to a plant-based LCD; however, an animal-based
LCD was associated with higher all-cause and cardiovascular
mortality.
Our results among MI survivors are not completely
consistent with our previous results with regard to primary
prevention of MI in these same cohorts.16,29 Halton et al found
that an LCD was not associated with increased risk of coronary
heart disease in women and that a diet low in carbohydrate but
high in plant sources of fat and protein moderately reduced
coronary heart disease risk.16 Fung et al showed that a plant-
based LCD was associated with lower all-cause and cardio-
vascular mortality in our populations that were free of
cardiovascular disease at baseline.29 In contrast, among MI
survivors, we did not ﬁnd a reduction in all-cause or cardio-
vascular mortality with a plant-based LCD. This may be due to
insufﬁcient power in our post-MI population, a relatively narrow
range of percentages of energy from vegetable protein and fat,
or lack of sufﬁcient follow-up after MI.
The results have also been mixed in other studies of LCDS
and primary prevention of cardiovascular disease and mortal-
ity.29–32 A high-protein LCD was associated with higher all-
cause and cardiovascular mortality after 12 years of follow-up
in a Swedish cohort of women.30 In a cohort from Greece,
consumption of an LCD was also associated with increased
all-cause mortality after 10 years of follow-up.31 In a separate
Swedish cohort with both men and women, a low high-protein
LCD was not associated with mortality.32 These discrepancies
Table 1. Continued
Women Men
Q1 Q3 Q5 Q1 Q3 Q5
Folate intake, lg/day 515 (282) 498 (262) 450 (269) 787 (421) 721 (370) 631 (395)
Chicken/turkey, servings/day 0.3 (0.2) 0.4 (0.2) 0.4 (0.2) 0.4 (0.2) 0.4 (0.2) 0.4 (0.3)
Total fish, servings/day 0.2 (0.2) 0.3 (0.2) 0.3 (0.2) 0.3 (0.2) 0.4 (0.3) 0.3 (0.2)
Total fruit, servings/day 2.6 (1.3) 2.4 (1.2) 2.0 (1.0) 3.2 (1.5) 2.6 (1.3) 2.0 (1.2)
Total vegetables, servings/day 2.8 (1.2) 2.9 (1.2) 2.8 (1.3) 3.5 (1.6) 3.3 (1.4) 3.0 (1.4)
Total red meat, servings/day 0.8 (0.4) 1.0 (0.5) 1.1 (0.6) 0.7 (0.5) 1.0 (0.5) 1.5 (0.8)
High-fat dairy, servings/day 1.1 (0.9) 1.2 (0.9) 1.4 (1.1) 0.9 (0.8) 1.1 (1.0) 1.4 (1.3)
Low-fat dairy, servings/day 1.1 (0.8) 1.1 (0.8) 0.9 (0.8) 1.1 (0.8) 1.3 (1.0) 1.1 (1.0)
Values are means (SD) or percentages and are standardized to the age distribution of the study population. Body mass index is calculated as weight in kilograms divided by the square
of height in meters. CABG indicates coronary artery bypass grafting; LCDS, low-carbohydrate diet score; MET, metabolic equivalent task; MI, myocardial infarction; n/a, not available;
PMH, postmenopausal hormone use; Q, quintile.
*Baseline diet and lifestyle factors are taken from participants’ ﬁrst post-MI questionnaire.
†Pre-MI diet is taken from participants’ most recent food frequency questionnaire before initial MI onset.
‡Change of diet from pre- to post-MI periods is calculated as: change=(post-MI dietpre-MI diet).
§Age is not age standardized.
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Table 2. Multivariate Adjusted Hazard Ratios for All-Cause and Cardiovascular Mortality According to Post-MI Low-Carbohydrate
Diet Score After Initial MI
Q1 Q2 Q3 Q4 Q5 Ptrend
All-cause mortality
Total LCDS
Women (n=682)
Median score 4 9 13 18 23
Cases per person-year 113/3855 139/4861 145/4273 143/4122 142/3909
Basic model-adjusted HR (95% CI)* 1.00 1.03 (0.80 to 1.33) 1.34 (1.04 to 1.73) 1.33 (1.03 to 1.72) 1.61 (1.24 to 2.08) <0.0001
Multivariate-adjusted HR (95% CI)† 1.00 1.06 (0.81 to 1.38) 1.36 (1.04 to 1.77) 1.31 (1.00 to 1.72) 1.31 (0.99 to 1.73) 0.02
Men (n=451)
Median score 4 9 12 17 24
Cases per person-year 93/3434 63/2580 88/3242 121/3920 86/2893
Basic model-adjusted HR (95% CI)* 1.00 0.88 (0.63 to 1.23) 0.96 (0.71 to 1.3) 1.15 (0.87 to 1.52) 1.16 (0.85 to 1.57) 0.12
Multivariate-adjusted HR (95% CI)† 1.00 1.03 (0.73 to 1.47) 0.96 (0.70 to 1.33) 1.23 (0.91 to 1.66) 0.90 (0.64 to 1.27) 0.94
Pooled
Multivariate-adjusted HR (95% CI) 1.00 1.05 (0.85 to 1.30) 1.18 (0.96 to 1.45) 1.27 (1.04 to 1.56) 1.13 (0.91 to 1.40)‡ 0.27
Plant-based LCDS
Women (n=682)
Median score 7 11 14 17 22
Cases per person-year 151/4214 144/4226 147/4294 129/4477 110/3778
Basic model-adjusted HR (95% CI)* 1.00 1.01 (0.80 to 1.28) 0.98 (0.78 to 1.24) 0.83 (0.65 to 1.06) 0.89 (0.69 to 1.15) 0.15
Multivariate-adjusted HR (95% CI)† 1.00 1.04 (0.82 to 1.33) 1.06 (0.83 to 1.36) 0.93 (0.72 to 1.20) 1.04 (0.79 to 1.37) 0.93
Men (n=451)
Median score 7 11 14 17 21
Cases per person-year 100/
3100
103/3428 99/3271 67/2842 82/3428
Basic model-adjusted HR (95% CI)* 1.00 0.94 (0.70 to 1.25) 0.96 (0.72 to 1.29) 0.82 (0.60 to 1.13) 0.84 (0.62 to 1.13) 0.18
Multivariate-adjusted HR (95% CI)† 1.00 0.93 (0.69 to 1.26) 0.92 (0.67 to 1.25) 0.84 (0.60 to 1.19) 0.85 (0.61 to 1.18) 0.28
Pooled
Multivariate-adjusted HR (95% CI) 1.00 1.01 (0.83 to 1.22) 1.00 (0.83 to 1.22) 0.91 (0.74 to 1.12) 0.95 (0.77 to 1.18)§ 0.70
Animal-based LCDS
Women (n=682)
Median score 3 8 13 18 25
Cases per person-year 115/3813 109/4370 142/4386 166/4470 149/3951
Basic model-adjusted HR (95% CI)* 1.00 0.91 (0.69 to 1.19) 1.25 (0.97 to 1.62) 1.52 (1.18 to 1.95) 1.57 (1.21 to 2.03) <0.0001
Multivariate-adjusted HR (95% CI)† 1.00 0.91 (0.68 to 1.20) 1.31 (1.00 to 1.72) 1.50 (1.15 to 1.96) 1.33 (1.01 to 1.77) 0.001
Men (n=451)
Median score 2 8 13 18 24
Cases per person-year 69/3055 90/3313 86/3491 100/2959 106/3250
Basic model-adjusted HR (95% CI)* 1.00 1.10 (0.80 to 1.53) 1.00 (0.72 to 1.39) 1.35 (0.99 to 1.85) 1.48 (1.08 to 2.02) 0.004
Multivariate-adjusted HR (95% CI)† 1.00 1.44 (1.02 to 2.04) 1.08 (0.76 to 1.53) 1.53 (1.08 to 2.15) 1.27 (0.89 to 1.81) 0.23
Pooled
Multivariate-adjusted HR (95% CI) 1.00 1.11 (0.89 to 1.38) 1.21 (0.98 to 1.51) 1.51 (1.22 to 1.87) 1.33 (1.06 to 1.65)k 0.02
Cardiovascular mortality
Total LCDS
Women (n=336)
Median score 4 9 13 18 23
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Table 2. Continued
Q1 Q2 Q3 Q4 Q5 Ptrend
Cases per person-year 48/3855 74/4861 67/4273 75/4112 72/3909
Basic model-adjusted HR (95% CI)* 1.00 1.34 (0.93 to 1.95) 1.57 (1.07 to 2.30) 1.72 (1.18 to 2.50) 1.94 (1.33 to 2.83) 0.33
Multivariate-adjusted HR (95% CI)† 1.00 1.36 (0.92 to 2.00) 1.49 (1.00 to 2.22) 1.72 (1.15 to 2.55) 1.46 (0.97 to 2.20) 0.82
Men (n=222)
Median score 4 9 12 17 24
Cases per person-year 48/3434 32/2580 40/3242 58/3920 44/2893
Basic model-adjusted HR (95% CI)* 1.00 0.89 (0.56 to 1.40) 0.82 (0.53 to 1.26) 1.10 (0.74 to 1.62) 1.17 (0.77 to 1.79) 0.26
Multivariate-adjusted HR (95% CI)† 1.00 0.97 (0.59 to 1.58) 0.75 (0.47 to 1.19) 1.11 (0.72 to 1.69) 0.93 (0.58 to 1.50) 0.91
Pooled
Multivariate-adjusted HR (95% CI) 1.00 1.20 (0.88 to 1.62) 1.11 (0.82 to 1.51) 1.40 (1.05 to 1.88) 1.21 (0.88 to 1.64)¶ 0.23
Plant-based LCDS
Women (n=336)
Median score 7 11 14 17 22
Cases per person-year 76/4214 61/4226 77/4294 72/4477 49/3778
Basic model-adjusted HR (95% CI)* 1.00 0.83 (0.59 to 1.18) 1.05 (0.75 to 1.45) 0.89 (0.64 to 1.24) 0.80 (0.55 to 1.15) 0.33
Multivariate-adjusted HR (95% CI)† 1.00 0.86 (0.60 to 1.23) 1.14 (0.81 to 1.61) 1.03 (0.73 to 1.46) 0.97 (0.65 to 1.44) 0.82
Men (n=222)
Median score 7 11 14 17 21
Cases per person-year 50/3100 56/3428 39/3271 33/2842 44/3428
Basic model-adjusted HR (95% CI)* 1.00 0.97 (0.65 to 1.43) 0.76 (0.50 to 1.18) 0.81 (0.51 to 1.27) 0.87 (0.58 to 1.33) 0.37
Multivariate-adjusted HR (95% CI)† 1.00 0.93 (0.61 to 1.42) 0.71 (0.45 to 1.12) 0.74 (0.45 to 1.21) 0.86 (0.54 to 1.38) 0.36
Pooled
Multivariate-adjusted HR (95% CI) 1.00 0.90 (0.68 to 1.18) 0.96 (0.73 to 1.26) 0.93 (0.70 to 1.23) 0.92 (0.68 to 1.25)# 0.59
Animal-based LCDS
Women (n=336)
Median score 3 8 13 18 25
Cases per person-year 49/3813 49/4370 72/4386 89/4470 76/3951
Basic model-adjusted HR (95% CI)* 1.00 0.97 (0.64 to 1.45) 1.50 (1.03 to 2.18) 1.89 (1.32 to 2.73) 1.84 (1.26 to 2.67) <0.0001
Multivariate-adjusted HR (95% CI)† 1.00 0.98 (0.64 to 1.50) 1.59 (1.06 to 2.36) 1.93 (1.31 to 2.85) 1.55 (1.03 to 2.33) 0.002
Men (n=222)
Median score 2 8 13 18 24
Cases per person-year 33/3055 46/3313 46/3491 49/2959 48/3250
Basic model-adjusted HR (95% CI)* 1.00 1.28 (0.81 to 2.03) 1.14 (0.72 to 1.81) 1.48 (0.94 to 2.32) 1.52 (0.96 to 2.40) 0.06
Multivariate-adjusted HR (95% CI)† 1.00 1.67 (1.02 to 2.71) 1.23 (0.75 to 2.01) 1.74 (1.06 to 2.85) 1.40 (0.83 to 2.36) 0.25
Pooled
Multivariate-adjusted HR (95% CI) 1.00 1.24 (0.90 to 1.70) 1.42 (1.04 to 1.94) 1.87 (1.38 to 2.53) 1.51 (1.09 to 2.07)** 0.02
CABG indicates coronary artery bypass grafting; CI, conﬁdence interval; HR, hazard ratio; LCDS, low-carbohydrate diet score; MI, myocardial infarction; Q, quintile.
*Adjusted for time since MI onset, age at diagnosis (continuous), calendar year (questionnaire cycle, continuous, 2-year period).
†Additionally adjusted for: total caloric intake (quintiles of kilocalories), physical activity (simple updated, quintiles of metabolic equivalents per week), aspirin use (yes or no), diabetes (yes
or no), high blood pressure (yes or no), lipid-lowering medication use (yes or no), alcohol consumption (0 g/day, 0.1 to 9.9 g/day, 10 to 29.9 g/day, or ≥30 g/day), currently married (yes
or no), body mass index (<21, 21 to 22.9, 23 to 24.9, 25 to 27.4, 27.5 to 29.9, >30 kg/m2), CABG (yes or no), and pre-MI score (quintiles). For women, additionally adjusted for
postmenopausal hormone use status (premenopause, postmenopausal hormone never user, postmenopausal hormone current user, postmenopausal hormone past user), and smoking
(never smoker or missing, past smoker, current smoker 1 to 14 cigarettes per day, current smoker 15 to 24 cigarettes per day, current smoker ≥25 cigarettes per day). For men,
additionally adjusted for heart failure (yes or no), left ventricular ejection fraction (≥40%, <40%, or missing), acute therapy during hospitalization (received either angioplasty or
thrombolytics, or none), and smoking (never smoker or missing, past smoker, current smoker <15 cigarettes per day, current smoker ≥15 cigarettes per day).
‡Pheterogeneity=0.10.
§Pheterogeneity=0.36.
kPheterogeneity=0.84.
¶Pheterogeneity=0.16.
#Pheterogeneity=0.70. **Pheterogeneity=0.09.
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Table 3. Multivariate Adjusted Hazard Ratios for All-Cause and Cardiovascular Mortality According to Changes of Low-
Carbohydrate Diet Score From Pre- to Post-MI Periods After Initial MI
Q1 Q2 Q3 Q4 Q5 P Trend
All-cause mortality
Total LCDS
Women (n=682)
Median score 12 6 1 3 9
Cases per person-year 137/4361 128/4300 130/4278 157/4092 130/3980
Basic model-adjusted HR (95% CI)* 1.00 1.06 (0.82 to 1.35) 1.12 (0.88 to 1.43) 1.30 (1.03 to 1.65) 1.11 (0.87 to 1.43) 0.13
Multivariate-adjusted HR (95% CI)† 1.00 1.14 (0.88 to 1.48) 1.32 (1.01 to 1.74) 1.55 (1.18 to 2.04) 1.35 (0.99 to 1.84) 0.01
Men (n=451)
Median score 12 6 2 2 8
Cases per person-year 93/3434 63/2580 88/3242 121/3920 86/2893
Basic model-adjusted HR (95% CI)* 1.00 1.06 (0.78 to 1.45) 0.78 (0.58 to 1.05) 0.89 (0.66 to 1.19) 0.99 (0.73 to 1.34) 0.62
Multivariate-adjusted HR (95% CI)† 1.00 1.28 (0.92 to 1.78) 0.85 (0.61 to 1.19) 0.99 (0.71 to 1.39) 0.94 (0.65 to 1.36) 0.52
Pooled
Multivariate-adjusted HR (95% CI) 1.00 1.19 (0.97 to 1.46) 1.10 (0.90 to 1.37) 1.30 (1.05 to 1.61) 1.16 (0.92 to 1.48)‡ 0.23
Plant-based LCDS
Women (n=682)
Median score 8 4 1 2 7
Cases per person-year 170/4418 107/3380 148/4992 136/4279 120/3921
Basic model-adjusted HR (95% CI)* 1.00 0.91 (0.71 to 1.17) 0.89 (0.71 to 1.12) 0.93 (0.74 to 1.18) 0.90 (0.71 to 1.15) 0.41
Multivariate-adjusted HR (95% CI)† 1.00 0.93 (0.71 to 1.21) 0.90 (0.70 to 1.16) 1.02 (0.79 to 1.32) 1.10 (0.82 to 1.47) 0.50
Men (n=451)
Median score 8 4 1 2 6
Cases per person-year 100/3100 103/3428 99/3271 67/2842 82/3428
Basic model-adjusted HR (95% CI)* 1.00 1.06 (0.78 to 1.43) 0.93 (0.69 to 1.24) 1.26 (0.94 to 1.70) 0.96 (0.71 to 1.30) 0.83
Multivariate-adjusted HR (95% CI)† 1.00 1.13 (0.82 to 1.57) 0.89 (0.64 to 1.23) 1.25 (0.89 to 1.75) 0.84 (0.59 to 1.20) 0.51
Pooled
Multivariate-adjusted HR (95% CI) 1.00 1.01 (0.82 to 1.23) 0.86 (0.70 to 1.05) 1.09 (0.89 to 1.35) 0.98 (0.78 to 1.23)§ 0.93
Animal-based LCDS
Women (n=682)
Median score 14 6 1 3 10
Cases per person-year 128/3974 127/4468 146/4751 141/3828 139/3969
Basic model-adjusted HR (95% CI)* 1.00 0.97 (0.75 to 1.25) 1.03 (0.80 to 1.32) 1.24 (0.97 to 1.58) 1.14 (0.89 to 1.47) 0.10
Multivariate-adjusted HR (95% CI)† 1.00 1.18 (0.90 to 1.55) 1.26 (0.95 to 1.66) 1.54 (1.16 to 2.04) 1.62 (1.19 to 2.20) 0.0005
Men (n=451)
Median score 14 7 3 2 9
Cases per person-year 69/3055 90/3313 86/3491 100/2959 106/3250
Basic model-adjusted HR (95% CI)* 1.00 0.80 (0.58 to 1.10) 0.95 (0.71 to 1.29) 0.93 (0.69 to 1.26) 0.96 (0.71 to 1.29) 0.91
Multivariate-adjusted HR (95% CI)† 1.00 0.96 (0.68 to 1.34) 1.10 (0.79 to 1.53) 1.06 (0.75 to 1.49) 0.95 (0.66 to 1.37) 0.89
Pooled
Multivariate-adjusted HR (95% CI) 1.00 1.09 (0.88 to 1.35) 1.19 (0.96 to 1.47) 1.32 (1.07 to 1.64) 1.30 (1.03 to 1.65)k 0.03
Cardiovascular mortality
Total LCDS
Women (n=336)
Median score 12 6 1 3 9
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Table 3. Continued
Q1 Q2 Q3 Q4 Q5 P Trend
Cases per person-year 64/4361 65/4300 68/4278 70/4092 69/3980
Basic model-adjusted HR (95% CI)* 1.00 1.23 (0.86 to 1.75) 1.35 (0.95 to 1.91) 1.37 (0.96 to 1.94) 1.32 (0.93 to 1.87) 0.09
Multivariate-adjusted HR (95% CI)† 1.00 1.37 (0.94 to 1.99) 1.65 (1.12 to 2.45) 1.55 (1.04 to 2.32) 1.53 (0.99 to 2.38) 0.05
Men (n=224)
Median score 12 6 2 2 8
Cases per person-year 48/3434 32/2580 40/3242 58/3920 44/2893
Basic model-adjusted HR (95% CI)* 1.00 1.29 (0.84 to 2.00) 0.99 (0.64 to 1.51) 0.93 (0.61 to 1.43) 1.06 (0.68 to 1.64) 0.76
Multivariate-adjusted HR (95% CI)† 1.00 1.58 (0.99 to 2.52) 1.06 (0.66 to 1.73) 1.03 (0.62 to 1.68) 0.91 (0.53 to 1.57) 0.41
Pooled
Multivariate-adjusted HR (95% CI) 1.00 1.46 (1.08 to 1.94) 1.39 (1.02 to 1.88) 1.32 (0.96 to 1.80) 1.25 (0.89 to 1.75)¶ 0.19
Plant-based LCDS
Women (n=336)
Median score 8 4 1 2 7
Cases per person-year 89/4418 46/3380 69/4992 70/4279 61/3921
Basic model-adjusted HR (95% CI)* 1.00 0.74 (0.51 to 1.06) 0.84 (0.61 to 1.16) 0.90 (0.65 to 1.24) 0.88 (0.63 to 1.24) 0.67
Multivariate-adjusted HR (95% CI)† 1.00 0.75 (0.51 to 1.10) 0.92 (0.64 to 1.31) 0.98 (0.68 to 1.41) 1.09 (0.72 to 1.65) 0.47
Men (n=224)
Median score 8 4 1 2 6
Cases per person year 50/3100 56/3428 39/3271 33/2842 44/3428
Basic model-adjusted HR (95% CI)* 1.00 1.03 (0.68 to 1.57) 0.94 (0.63 to 1.40) 1.18 (0.77 to 1.79) 0.78 (0.50 to 1.21) 0.45
Multivariate-adjusted HR (95% CI)† 1.00 1.10 (0.70 to 1.74) 0.99 (0.62 to 1.56) 1.28 (0.79 to 2.10) 0.77 (0.46 to 1.30) 0.49
Pooled
Multivariate-adjusted HR (95% CI) 1.00 0.88 (0.66 to 1.19) 0.95 (0.71 to 1.26) 1.08 (0.80 to 1.45) 0.96 (0.69 to 1.32)# 0.76
Animal-based LCDS
Women (n=336)
Median score 14 6 1 3 10
Cases per person-year 60/3974 61/4468 63/4751 72/3828 79/3969
Basic model-adjusted HR (95% CI)* 1.00 1.07 (0.74 to 1.54) 1.09 (0.76 to 1.57) 1.45 (1.02 to 2.06) 1.38 (0.98 to 1.96) 0.02
Multivariate-adjusted HR (95% CI)† 1.00 1.31 (0.89 to 1.93) 1.37 (0.91 to 2.05) 1.78 (1.20 to 2.65) 1.97 (1.29 to 3.03) 0.0006
Men (n=224)
Median score 8 4 1 2 6
Cases per person-year 33/3055 46/3313 46/3491 49/2959 48/3250
Basic model-adjusted HR (95% CI)* 1.00 1.01 (0.65 to 1.59) 1.15 (0.74 to 1.78) 1.02 (0.65 to 1.58) 1.15 (0.76 to 1.76) 0.54
Multivariate-adjusted HR (95% CI)† 1.00 1.14 (0.71 to 1.84) 1.27 (0.78 to 2.08) 1.04 (0.63 to 1.72) 1.03 (0.61 to 1.74) 0.87
Pooled
Multivariate-adjusted HR (95% CI) 1.00 1.24 (0.92 to 1.67) 1.33 (0.98 to 1.81) 1.45 (1.06 to 1.98) 1.53 (1.10 to 2.13)** 0.01
CABG indicates coronary artery bypass grafting; CI, conﬁdence interval; HR, hazard ratio; LCDS, low-carbohydrate diet score; MI, myocardial infarction.
*Adjusted for time since MI onset, age at diagnosis (continuous), calendar year (questionnaire cycle, continuous, 2-year period).
†Additionally adjusted for aspirin use (never taker, new taker, always taker), diabetes(no diabetes, new diabetes, always diabetes), high blood pressure (no high blood pressure, new high
blood pressure, always high blood pressure), lipid-lowering medication use (never taker, new taker, always taker), married (never married, always married, not married anymore), CABG
(never CABG, always CABG, new CABG), changes in smoking status (always never smoker, always past smokers, always current smoking 1 to 14 cigarettes per day post-MI period, always
current smoking ≥15 cigarettes per day post-MI period, quit smoking after MI 1 to 14 cigarettes per day pre-MI period, quit smoking after MI ≥15 cigarettes per day pre-MI period), and
pre-MI score (quintiles). For women, additionally adjusted for changes in total caloric intake (quintiles of kilocalories), changes in physical activity (quintiles of changes in metabolic
equivalents per week), changes in alcohol consumption (quintiles of changes in g/day), changes in body mass index (quintiles of changes in kg/m2), and postmenopausal hormone use
status (simple updated, premenopause, postmenopausal hormone never user, postmenopausal hormone current user, postmenopausal hormone past user). For men, additionally adjusted
for changes in total caloric intake (tertiles of kilocalories), changes in physical activity (tertiles of changes in metabolic equivalents per week), changes in alcohol consumption (tertiles of
changes in g/day), changes in body mass index (tertiles of changes in kg/m2), heart failure (simple updated, yes or no), left ventricular ejection fraction (simple updated, ≥40%, <40%, or
missing), and acute therapy during hospitalization (simple updated, received either angioplasty or thrombolytics, or none).
‡Pheterogeneity=0.13.
§Pheterogeneity=0.25.
kPheterogeneity=0.03.
¶Pheterogeneity=0.16.
#Pheterogeneity=0.31. **Pheterogeneity=0.06.
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may be due to differences in the underlying degree of
hyperglycemia and insulin resistance in the study populations
or in the sources of foods represented in the LCDs from these
populations.33 It is difﬁcult to compare these results with
those from our cohorts because none reported separately on
animal or plant sources of fats and proteins.
Even within our own cohorts, the mortality rates associated
with an animal-based LCD may differ depending on the
composition of the food sources. The fat consumed from an
animal-based LCD, for example, could be greater in saturated
fat from high-fat dairy or red meat and processed meat or
could be higher in eicosapentaenoic acid and docosahexae-
noic acid if consumed mainly from fatty ﬁsh. We did not have
enough high ﬁsh consumption to further separate the animal-
based LCDs into LCDs high in red meat or dairy fat or high in
ﬁsh, although the participants with the highest total LCDSs
had greater intake of red meat and high-fat diary and less
consumption of dietary ﬁber. In a previous study in these
same populations, better overall diet quality after MI was
associated with substantially lower all-cause and cardiovas-
cular mortality.34 In our analyses, associations with animal-
based LCDs were attenuated after additionally adjusting for
saturated fat intake. This suggests that the higher mortality
may be due, in part, to saturated fat intake in the animal-
based LCDs.
We and others have reported an association between
glycemic load and elevated risk of diabetes and cardiovascu-
lar disease.35–40 One limitation of using the LCDS to assess
total carbohydrates is that it cannot differentiate carbohy-
drate quality. Reﬁned carbohydrates can be digested rapidly
and can generate elevated concentrations of blood glucose
and insulin demand that may ultimately lead to lipid and
inﬂammation disorders after MI.41,42 In contrast, an LCD
could also be low in whole grains and dietary ﬁber, both of
which—when consumed in greater amounts—have been
associated with a 20% to 40% lower risk of coronary heart
disease in the general population.36,43,44 Results in our study
were similar after we additionally adjusted for cereal ﬁber in
the model. The study was underpowered to explore this
dimension of carbohydrate quality, but future larger studies of
MI survivors should explore the speciﬁc attributes of carbo-
hydrates when assessing health risks associated with adher-
ence to an LCD.
Our study has several other limitations. Because of the
observational nature of the study, there may be residual or
unmeasured confounding that was not captured in our
multivariate adjustment. In addition, in the Nurses’ Health
Study, we did not collect detailed clinical characteristics or
treatment during hospitalization and thus could not adjust for
these factors in the analyses. For men, the results were
Total mortality Cardiovascular mortality
2
1
1.5
0.80
0.60
Figure. Multivariate adjusted hazard ratios (HRs) for all-cause and cardiovascular mortality comparing new
adherents versus nonadherents (n=1059 for women, with 294 new adherents and 765 nonadherents;
n=804 for men, with 216 new adherents and 588 nonadherents). LCDS indicates low-carbohydrate diet
score.
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similar both with and without adjustment for these charac-
teristics, so this limitation does not seem likely confound our
overall associations. In our study we found that the associ-
ations with LCD after MI were stronger for women than for
men; however, there was no signiﬁcant heterogeneity
between sexes. The discrepancy may be due to the limited
number of events in the extreme quintiles; the greater case-
fatality rate among women; or the differences in MI patho-
physiology, clinical presentation, initial management, and
prognosis.45 Future studies are needed to investigate this.
The case-fatality rate in our cohorts may be different from
other MI-survivor populations because our participants were
all health professionals and may have had better access to
acute care. Nonetheless, it is unlikely that the underlying
biology associated with an LCD would differ dramatically,
regardless of survivorship differences.
We acknowledge a degree of measurement error associ-
ated with using the FFQ to assess average diet. Previous
validation studies in our cohorts have shown that the self-
reported FFQ is valid and reliable for measuring average
dietary intake.19,20,46 Although the FFQ was validated among
healthy participants, it is unlikely to be substantially different
among post-MI populations. If anything, bias in assessment of
an LCDS is likely to be random because of the prospective
nature of the study and thus would bias our results toward the
null. The LCDS was originally developed in our cohorts and has
not been formally validated; however, estimated micro- and
macronutrient intakes in our cohorts have been validated.
The dietary LCDS calculated from the FFQ was limited to
participants who had at least 1 pre- and post-MI dietary
assessment. The participants who died before the return of
the ﬁrst post-MI FFQ or who had all post-MI FFQs missing
were not included in the study. If participants who were most
susceptible to the detrimental (or beneﬁcial) effects of an LCD
died, this could potentially introduce a survival bias, which
would likely attenuate any true association towards the null;
however, the results were similar after using inverse proba-
bility weighting to account for this potential survival bias.
Another limitation of our study is that we do not have
biomarker information on the whole population and thus could
not evaluate the speciﬁc biological mechanisms responsible
for any potential risk reduction.
In our prospective study evaluating the long-term associ-
ation between adherence to an LCD and mortality among MI
survivors, we provided the ﬁrst evidence that, overall, an LCD
after MI was not associated with all-cause or cardiovascular
mortality. We did not ﬁnd a beneﬁt for better adherence to a
plant-based LCD; however, adherence to an LCD high in
animal sources of fat and protein was associated with higher
all-cause and cardiovascular mortality. MI patients who intend
to follow an LCD should avoid consuming mainly animal
sources of fat and protein.
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